Enhanced Accuracy of Cardiovascular Risk Assessment through New Study Findings
A new study validates the effectiveness of the PREVENT cardiovascular risk tool across diverse Asian and Hispanic populations, enhancing personalized heart disease prevention strategies.
Recent research conducted by Sutter Health and Stanford University has demonstrated that the American Heart Association's PREVENT equations provide reliable predictions for cardiovascular disease (CVD) risk across diverse Asian and Hispanic populations. The study analyzed over 361,000 primary care patients aged 30 to 79 years from Sutter Health’s extensive network in Northern California, spanning urban, suburban, and rural communities, from January 2010 to September 2023.
The researchers evaluated the performance of these risk prediction models over an average follow-up period of 8.1 years, during which approximately 6.3% of participants experienced a CVD event. The results showed high predictive accuracy for total CVD, atherosclerotic cardiovascular disease (ASCVD), and heart failure across different ethnic subgroups, with only modest variations observed.
The study highlighted that the PREVENT models performed well across various Asian and Hispanic subpopulations, although some differences in the accuracy for ASCVD and heart failure were noted. This indicates the potential for these tools to be more effectively tailored to diverse patient groups, contributing to better risk stratification and personalized care.
Therefore, as the U.S. population ages and the burden of heart disease continues to grow, accurate risk prediction models like PREVENT are vital for guiding preventative strategies. Dr. Xiaowei Yan from Sutter Health emphasized that these findings could inform improved clinical practices, especially for communities historically underrepresented in CVD research. However, the study also acknowledged limitations, such as the inability to fully analyze all Asian and Hispanic subgroups and small sample sizes for some groups.
Looking ahead, future research may focus on establishing clear treatment thresholds based on PREVENT risk estimates to enhance clinical decision-making. Overall, this study underscores the importance of inclusive, precise cardiovascular risk assessment to advance health outcomes for all populations.
Source: https://medicalxpress.com/news/2025-07-hone-precision-proven-cardiovascular-disease.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Supporting Continued Use of Nasogastric Tubes Post-Esophageal Cancer Surgery
Large Nordic study confirms that using nasogastric tubes after esophageal cancer surgery reduces serious complications and prevents leaks, emphasizing the importance of evidence-based surgical practices.
Inhaled Heparin Shows Promise in Reducing Ventilation Needs and Mortality in Severe COVID-19 Cases
Inhaled heparin has demonstrated effectiveness in reducing the need for ventilation and lowering mortality rates among severe COVID-19 patients, offering a promising treatment avenue for respiratory infections.
New Research Finds Rapamycin Extends Lifespan Similar to Caloric Restriction
Recent research reveals that rapamycin, a drug used to prevent organ rejection, can extend lifespan nearly as effectively as dietary restriction, offering promising insights into anti-aging therapies. Ongoing human trials aim to confirm these benefits with minimal side effects, opening new avenues for healthier aging.
Osteoporosis Treatment Benefits for Individuals Over 80 Years Old
New research suggests that osteoporosis treatment for individuals over 80 who suffer fractures can significantly reduce hospitalization and mortality, emphasizing the importance of personalized care in aging populations.